NEW YORK ( TheStreet) -- Allergan ( AGN) was downgraded to at Deutsche Bank to hold and given a new price target of $98. Allergan's risk profile and future earnings estimates suffered as the FDA announced a nonclinical study pathway for generics to produce Restasis, AGN's second largest drug, Deutsche said. Allergan was downgraded at Leerink Swann. Future earnings estimates have been lowered as concern mounts over generic production of the firm's second largest drug, said Leerink Swann. New market perform rating, price target $102. Advanced Micro ( AMD) was upgraded at FBR Capital Markets to outperform from market perform. $5.50 price target. Business appears to have stabilized for now, FBR Capital Markets said. CBOE ( CBOE) was upgraded to buy at Goldman Sachs. $47 price target. Company is leveraged to an increase in volatility, Goldman said. CME ( CME) was upgraded at Goldman Sachs to neutral from sell. Valuation call, based on a $70 price target, Goldman said. CNL) was downgraded at Goldman Sachs to neutral from buy. Estimates were also cut, as the company is buying back fewer shares, Goldman Sachs said. Deere ( DE) was downgraded at J.P.Morgan to underweight from neutral. U.S. crop fundamentals have passed their peak, J.P. Morgan said. Digital Realty Trust ( DLR) was upgraded at UBS to neutral from sell. The risk/reward is balanced at current levels, UBS said. Eaton Vance ( EV) was upgraded at Citigroup to neutral from sell. There's an expectation for a pickup in U.S.-centric flows, said Citigroup. First Solar ( FSLR) was initiated with an overweight rating at J.P. Morgan. $64 price target. Company should benefit from industry consolidation, J.P. Morgan said. GGG) was upgraded at Goldman Sachs to neutral from sell. $68 price target. Company has solid margins and can exceed earnings expectations, Goldman Sachs said. Iron Mountain ( IRM) was downgraded to hold at TheStreet Ratings. Hub Group ( HUBG) was downgraded at Wells Fargo to underperform from market perform. Company is losing its pricing power, Wells Fargo said. Illinois Tool ( ITW) was downgraded at Goldman Sachs. Valuation call, based on a $69 price target, Goldman said. Landstar ( LSTR) was downgraded at Wells Fargo to market perform from outperform. Industry competition is rising, Wells Fargo said.
PHH ( PHH) was upgraded at Compass Point to buy from neutral. $26 price target. Company could boost earnings by paying debt early and may be a takeover candidate, Compass Point said. Portland General ( POR) was upgraded at Goldman Sachs to buy from neutral. Company has an attractive valuation and can deliver strong earnings growth, Goldman Sachs said. PVH ( PVH) was upgraded at Piper Jaffray to overweight from neutral. $121 price target. Visibility catalysts are improving, Piper Jaffray said. Praxair ( PX) was downgraded at Citigroup to neutral. Slower growth in China and Brazil and slowing backlog, said Citigroup. Rovi ( ROVI) was downgraded at Pacific Crest to underperform. Limited growth prospects and lower earnings projections, Pacific Crest said. Recent settlements and negative rulings suggest weakening patent value, Pacific Crest also said. SCHW) was upgraded at Citigroup to buy from sell, as rate expectations shift and earnings normalize, said Citigroup. Price target goes to $24. Sherwin-Williams ( SHW) was initiated with a buy rating at UBS. $215 price target. Best-in-class play on pro paint volume increases, UBS said. T. Rowe Price ( TROW) was upgraded at Citigroup to buy as U.S. retail cash flows back into domestic equities, said Citigroup. Price target goes to $82. Valspar was downgraded at Citigroup to neutral. Reflects the impact of declines in mining capex on the company, said Citigroup. Price target goes to $73. Vicon ( VII) was downgraded to sell at TheStreet Ratings. Walgreen ( WAG) was downgraded at Cantor Fitzgerald to hold from buy. Valuation call, based on a $49 price target, Cantor said. Westlake ( WLK) was upgraded at Cowen to outperform from market perform. $112 price target Estimates were also boosted, given higher expected ethylene margins, Cowen said.